SCIENTIFIC PROGRAMME
288
WEDNESDAY
THURSDAY
FRIDAY
SATURDAY
S-104
Symposium
17.15– 18.45 h
|
Room Weimar 3
TOPIC 3:
Psychotic disorders, F2
The role of oligodendrocytes in symp-
tom dimensions of schizophrenia
Chairs:
Johann Steiner, Magdeburg
(Germany)
Andrea Schmitt, Munich (Germany)
001
The impact of white matter micro-
structure on clinical symptoms: insights
from DTI studies
Berend Malchow, Munich (Germany)
002
Clinical heterogeneity in schizophre-
nia is associated with the heterogeneity
of oligodendrocyte abnormalities
Natalya Uranova, Moscow (Russia)
003
Oligodendrocyte number in brain
regions of schizophrenia patients and
association with cognitive deficits
Andrea Schmitt, Munich (Germany)
Berend Malchow, Hans-Gert Bernstein,
Johann Steiner, Christoph Schmitz, Bernhard
Bogerts, Verena Nowastowski, Katharina
Wetzestein, Peter Falkai
004
Increased nuclear Olig1-expression:
a regenerative attempt to compensate
oligodendrocyte loss?
Johann Steiner, Magdeburg (Germany)
Jennifer Mosebach, Gerburg Keilhoff,
Kolja Schiltz, Hans-Gert Bernstein,
Bernhard Bogerts
S-105
Symposium
17.15– 18.45 h
|
Room M5
TOPIC 23:
Health care research and models
Person-centered psychiatry and medicine
– concept and application
Chairs:
Wolfgang Gaebel, Dusseldorf
(Germany)
Juan E. Mezzich, New York (USA)
001
Conceptual bases and international
development of person-centered psychia-
try and medicine
Juan E. Mezzich, New York (USA)
002
European perspectives on per-
son-centered psychiatry
Wolfgang Gaebel, Dusseldorf (Germany)
003
The International College of person
centered medicine and its life course
projections
James Appleyard, London (United Kingdom)
004
The World Medical Association and
person centered medicine
Otmar Kloiber, Ferney-Voltaire (France)